Holen Sie sich die Stockscreener-App
5.775
10.74%
-0.695
Handel nachbörslich:
5.85
0.075
+1.30%
Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
37.48%
11.18
|
8.13 | 8.757 | 8.571 | 7.902 |
| Interest Income/Expense |
22.88%
0.236
|
0.306 | 0.487 | 0.567 | 0.646 |
| Operating Income/Loss |
37.48%
-11.18
|
-8.13 | -8.757 | -8.571 | -7.902 |
| Nonoperating Income/Loss |
58.86%
6.381
|
15.51 | -1.889 | -13.67 | -0.319 |
| Income/Loss From Continuing Operations Before Tax |
165.00%
-4.796
|
7.379 | -10.65 | -22.24 | -8.221 |
| Income/Loss From Continuing Operations After Tax |
165.00%
-4.796
|
7.379 | -10.65 | -22.24 | -8.221 |
|
Net Income/Loss
|
165.00%
-4.796
|
7.379 | -10.65 | -22.24 | -8.221 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2.00%
51.49
|
50.48 | 32.01 | 29.88 | 29.20 |
| Diluted Average Shares |
5.98%
51.49
|
54.77 | 32.01 | 29.88 | 29.20 |
| Basic Earnings Per Share |
160.00%
-0.09
|
0.15 | -0.33 | -0.74 | -0.28 |
| Diluted Earnings Per Share |
169.23%
-0.09
|
0.13 | -0.33 | -0.74 | -0.28 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):